Igen v. Roche
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics maintains that a judge's February ruling bars Igen from using its Origen biological detection technology and Roche's improvements, including the Elecsys lines of clinical diagnostic immunoassay analyzers and tests developed for those systems, in central labs, blood banks and hospitals. However, Igen disputes the claim, arguing that after termination of an existing license agreement, permitted by a Jan. 10 Maryland federal court jury verdict, the firm will be free to use the technology in Roche's fields as well as non-licensed fields (1"The Gray Sheet" Jan. 14, 2002, p. 31). Igen has notified Roche that the license terminates immediately once the final judgement is affirmed by the court of appeals. Roche expects the appeals process to continue until the second half of 2003...